ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Anaptysbio Inc

Anaptysbio Inc (0HFQ)

86.95
0.00
(0.00%)
Closed December 30 10:30AM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
86.95
Bid
0.00
Ask
0.00
Volume
164
0.00 Day's Range 0.00
86.95 52 Week Range 86.95
Market Cap
Previous Close
86.95
Open
-
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
862
Shares Outstanding
26,575,000
Dividend Yield
-
PE Ratio
-2.08
Earnings Per Share (EPS)
-6.16
Revenue
17.16M
Net Profit
-163.62M

About Anaptysbio Inc

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
-
Anaptysbio Inc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0HFQ. The last closing price for Anaptysbio was US$86.95. Over the last year, Anaptysbio shares have traded in a share price range of US$ 86.95 to US$ 86.95.

Anaptysbio currently has 26,575,000 shares outstanding. The market capitalization of Anaptysbio is US$2.31 billion. Anaptysbio has a price to earnings ratio (PE ratio) of -2.08.

0HFQ Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10086.9586.9586.9514186.95DE
40086.9586.9586.95167686.95DE
120086.9586.9586.9586286.95DE
260086.9586.9586.9549386.95DE
520086.9586.9586.9528586.95DE
1560086.9586.9586.9514986.95DE
2600086.9586.9586.9510886.95DE

0HFQ - Frequently Asked Questions (FAQ)

What is the current Anaptysbio share price?
The current share price of Anaptysbio is US$ 86.95
How many Anaptysbio shares are in issue?
Anaptysbio has 26,575,000 shares in issue
What is the market cap of Anaptysbio?
The market capitalisation of Anaptysbio is USD 2.31B
What is the 1 year trading range for Anaptysbio share price?
Anaptysbio has traded in the range of US$ 86.95 to US$ 86.95 during the past year
What is the PE ratio of Anaptysbio?
The price to earnings ratio of Anaptysbio is -2.08
What is the cash to sales ratio of Anaptysbio?
The cash to sales ratio of Anaptysbio is 19.84
What is the reporting currency for Anaptysbio?
Anaptysbio reports financial results in USD
What is the latest annual turnover for Anaptysbio?
The latest annual turnover of Anaptysbio is USD 17.16M
What is the latest annual profit for Anaptysbio?
The latest annual profit of Anaptysbio is USD -163.62M
What is the registered address of Anaptysbio?
The registered address for Anaptysbio is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Anaptysbio website address?
The website address for Anaptysbio is www.anaptysbio.com
Which industry sector does Anaptysbio operate in?
Anaptysbio operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CLAICel Ai Plc
0.085p
(41.67%)
20.31M
ZEDZenova Group Plc
0.675p
(22.73%)
3.96M
GFINGfinity Plc
0.07p
(21.74%)
109.16M
PRMProteome Sciences Plc
4.10p
(19.88%)
67.23k
VRCIVerici Dx Plc
3.875p
(19.23%)
679.37k
QUIZQuiz Plc
0.745p
(-15.82%)
5.25M
SRESSunrise Resources Plc
0.0275p
(-15.38%)
43.75M
PPSProton Motor Power Systems Plc
0.275p
(-15.38%)
401.8k
SYMESupply@me Capital Plc
0.0034p
(-13.92%)
511.77M
PREMPremier African Minerals Limited
0.044p
(-12.87%)
291.61M
TRPTower Resources Plc
0.037p
(8.82%)
983.58M
SYMESupply@me Capital Plc
0.0034p
(-13.92%)
511.77M
NTVONativo Resources Plc
0.002p
(0.00%)
399.34M
PREMPremier African Minerals Limited
0.044p
(-12.87%)
291.61M
CPXCap-xx Limited
0.1525p
(3.39%)
264.9M

Discussion

View Full Feed
Eagle1 Eagle1 32 seconds ago
Good Morning All, like this one too RVPH 1.8797 0.0797 (4.43%) 12-30-24
RVPH
GTF GTF 36 seconds ago
This mornings incredible post:
https://x.com/ABIntlGroup/status/1873748749572518301
ABQQ
Magnum7419 Magnum7419 37 seconds ago
wow talk about painting the tape............1 share,sold

nasd
10:05:52 0.0009 1 Sell 0.0009 0.001
AHRO
Wayne R Wayne R 51 seconds ago
Where there is life there is hope
bucks2pennies bucks2pennies 1 minute ago
No report of O/S increase for some time now. 16.8B+ remains the same as of 12/23/24 per OTC
GTCH
threewheeler threewheeler 1 minute ago
BOPO tax loss selling some body, and nothing we can do about buying these, talk about sux
BOPO
saj saj 1 minute ago
Buru nice move today over .7
glenn1919 glenn1919 1 minute ago
erna.......................https://stockcharts.com/h-sc/ui?s=erna&p=W&b=5&g=0&id=p86431144783
ERNA
jour_trader jour_trader 1 minute ago
Also, the price will be for 30, 60 or 90 bottles so don't we need to take capsule production max of 57K per 8 hour shift and divide by at least 30? We'd then take this and apply it to about 50% of price we see on GoodRx for a reasonable estimate for Elite revenue after pharmacy, distributor & other
ELTP
prototype_101 prototype_101 2 minutes ago
Hero EXACTLY 💯 in addition to Leonberger buying up 100,000 options outright and disposing ZERO, a couple more things he could consider,

1) the latest round of Annual Incentive Comps were issued at $5 strike, and this was at a time the PPS was in 3's

2) the new C
LWLG
AJH92 AJH92 2 minutes ago
Update - December 30: "United States Citizenship and Immigration Services (USCIS) has released processing data for EB-5 visa petitions through Q4 FY2024. The data includes the filings, approvals, denials, and pending cases of Form I-526 legacy, I-526, and I-526E petition for regional center investor
PSRU
tw0122 tw0122 2 minutes ago
.90s +30%%
JDZG
DaJester DaJester 2 minutes ago
One other thing that I think you are misunderstanding: I think Treasury will end up with 80-99.9% of the final share count, i.e. after considering a junior-to-common conversion and capital raise.

I think this is the fundamental difference in theories. It's going to be exceedingly diff
FNMA
stockprofitter stockprofitter 2 minutes ago
He doesn’t work for the government
FNMA
Wayne R Wayne R 2 minutes ago
You sound like Dylan Hunt

https://g.co/kgs/8k8Q7aj
rosemountbomber rosemountbomber 2 minutes ago
They have been waiting for the new formulation to weave its way through the patent and FDA approval processes.

Do we know if they have actually started the approval process with the FDA? Isn't that material information that they would need to release?

Also, I like the
AMRN
tw0122 tw0122 2 minutes ago
.93
JDZG
dexprs dexprs 2 minutes ago
We may have seen the short term bottom this morning. I am changing my tactics accordingly and will be adding larger positions.
FFFacts FFFacts 2 minutes ago
Why do we only see positive statement gains but never losses from the dishonorably discharged?
FNMA
DewDiligence DewDiligence 3 minutes ago
It’s just under 10% of my overall investment portfolio, but it’s about 30% of the drug/biotech portion of my portfolio.
Trooperstocks Trooperstocks 3 minutes ago
$RELT - The acquisition began as early as March of 2023, but its more recent strategic transformation underscores ONAR's visionary drive to position the agency at the forefront of the healthcare marketing industry. As ONAR expands its expertise to new and emerging markets, Of Kos aligns with its rob
RELT
LowFloatLopes LowFloatLopes 3 minutes ago
Bye bye wall 
HOLO
Trooperstocks Trooperstocks 3 minutes ago
$RELT - The acquisition began as early as March of 2023, but its more recent strategic transformation underscores ONAR's visionary drive to position the agency at the forefront of the healthcare marketing industry. As ONAR expands its expertise to new and emerging markets, Of Kos aligns with its rob
RELT
Omar8 Omar8 3 minutes ago
AlwaysRed,





Dropping to fill those last contracts ?


https://www.cmegroup.com/markets/metals/precious/silver.volume.html
SLV
barttt barttt 3 minutes ago
What is our market cap now?  Seems pretty low for owning a 20mil revenue/year furniture company 
ASKH

Your Recent History

Delayed Upgrade Clock